Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Expert Opinion on Drug Safety
|
November 18, 2014
Weight gain and antipsychotics: a drug safety review
Richard Musil, Michael Obermeier, Paul Russ, et al.
Fortschritte Der Neurologie-Psychiatrie
|
October 19, 2019
[Patients with tic disorders: widely known, yet underserved]
Jaana M L Schnell, Elif Weidinger, Richard Musil
Current Psychiatry Reports
|
April 6, 2012
Functional outcomes in schizophrenia: employment status as a metric of treatment outcome
Rebecca Schennach, Richard Musil, Hans-Jürgen Möller, et al.
BMC Medicine
|
February 17, 2012
Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
Florian Seemüller, Hans-Jürgen Möller, Sandra Dittmann, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
February 23, 2013
Treatment Response in First-episode Schizophrenia
Rebecca Schennach, Michael Riedel, Richard Musil, et al.
European Journal of Clinical Pharmacology
|
August 19, 2025
Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and metabolic ratio in a naturalistic setting
Kajetan Nierychlewski, Michael Paal, Sebastian Meinzer, et al.
Plos One
|
July 21, 2022
A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol
Maria S Simon, Barbara B Barton, Catherine Glocker, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
July 15, 2019
Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study
Barbara B Barton, Anja Zagler, Katharina Engl, et al.
Expert Opinion on Drug Safety
|
January 19, 2020
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
Barbara B Barton, Felix Segger, Kai Fischer, et al.
Alpha Psychiatry
|
January 20, 2025
Development and Evaluation of the "Eating More Consciously" Module of a Lifestyle Intervention Program to Prevent Medication-Induced Weight Gain in Psychiatric Patients: A One-Arm Pilot Study
Catherine Glocker, Maria S Simon, Nicole Adler, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Expert Opinion on Drug Safety
|
November 18, 2014
Weight gain and antipsychotics: a drug safety review
Richard Musil, Michael Obermeier, Paul Russ, et al.
Fortschritte Der Neurologie-Psychiatrie
|
October 19, 2019
[Patients with tic disorders: widely known, yet underserved]
Jaana M L Schnell, Elif Weidinger, Richard Musil
Current Psychiatry Reports
|
April 6, 2012
Functional outcomes in schizophrenia: employment status as a metric of treatment outcome
Rebecca Schennach, Richard Musil, Hans-Jürgen Möller, et al.
BMC Medicine
|
February 17, 2012
Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
Florian Seemüller, Hans-Jürgen Möller, Sandra Dittmann, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
February 23, 2013
Treatment Response in First-episode Schizophrenia
Rebecca Schennach, Michael Riedel, Richard Musil, et al.
European Journal of Clinical Pharmacology
|
August 19, 2025
Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and metabolic ratio in a naturalistic setting
Kajetan Nierychlewski, Michael Paal, Sebastian Meinzer, et al.
Plos One
|
July 21, 2022
A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol
Maria S Simon, Barbara B Barton, Catherine Glocker, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
July 15, 2019
Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study
Barbara B Barton, Anja Zagler, Katharina Engl, et al.
Expert Opinion on Drug Safety
|
January 19, 2020
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
Barbara B Barton, Felix Segger, Kai Fischer, et al.
Alpha Psychiatry
|
January 20, 2025
Development and Evaluation of the "Eating More Consciously" Module of a Lifestyle Intervention Program to Prevent Medication-Induced Weight Gain in Psychiatric Patients: A One-Arm Pilot Study
Catherine Glocker, Maria S Simon, Nicole Adler, et al.
Page
of 9